Zhuhai Deere Bioengineering Co., Ltd.

DL Mission

Provides users with high-quality innovative microbiological testing solutions

DL Mission

Provides users with high-quality innovative microbiological testing solutions

넳 넲

Zhuhai DL Biotechnology Co., Ltd. is a leading high-tech enterprise specializing in pathogenic microorganism diagnostics. Established in 2003, the company focuses on clinical microbiological diagnostics, serving over 5,000 medical institutions worldwide. With independent research laboratories and subsidiaries in the United States fully owned by the company, Di'er Biotech is recognized for its over 300 national patents and commitment to independent research and development. Its core products cover microbial culture, morphological detection, drug susceptibility testing, and molecular genetic testing. Through advanced automation and information technologies, it provides rapid microbial detection systems, contributing to the rational use of antibiotics and combating drug-resistant bacteria, thereby addressing health challenges.

Learn More >

NEW PRODUCT

Product Center

넳 넲

NEWS CENTER

News Center

Human BRCA1 and BRCA2 Mutation Detection Kit (Reversible Unterminated Sequencing)

BRCAU developed based on independent patent NGS control (China invention train number: ZL 201610134675.4) BRCAU developed based on independent patent NGS control (China invention train number: ZL 201610134675.4)

Learn More >

Human BRCA1 and BRCA2 Mutation Detection Kit (Reversible Unterminated Sequencing)

BRCAU developed based on independent patent NGS control (China invention train number: ZL 201610134675.4) BRCAU developed based on independent patent NGS control (China invention train number: ZL 201610134675.4)

Learn More >

Human BRCA1 and BRCA2 Mutation Detection Kit (Reversible Unterminated Sequencing)

BRCAU developed based on independent patent NGS control (China invention train number: ZL 201610134675.4) BRCAU developed based on independent patent NGS control (China invention train number: ZL 201610134675.4)

Learn More >

넳 넲

Solution

Constructing a rapid detection system for pathogenic microorganisms

Clinical Microbiology Solutions

Clinical microbiological testing is crucial for diagnosing infectious diseases and guiding medication in hospitals. However, challenges like long turnaround times, complex procedures, and ineffective clinical guidance exist. Di'er Biotech offers automated solutions,

图片标题

Non-Clinical Microbiology

In 2016, China issued a national action plan to combat antimicrobial resistance. Di'er Biotech's industrial microbial detection platform helps pharmaceutical, food, and livestock industries monitor pathogenic bacteria for production safety.

图片标题

CHICARD150Drug Sensitivity Card

Added ceftazidime/avibactam, aztreonam/avibactam, ceftaroline, nanofloxacin, elacycline and other drugs to effectively deal with multi-drug resistant bacteria infection.

Learn More >